Fleishman-Hillard has named Anne de Schweinitz as senior vice-president, senior partner and managing director of the Fleishman-Hillard healthcare group. She replaces Michael Rinaldo and will relocate from New York to F-H's London office,reporting directly to John Saunders, president of the agency's EMEA region.
Astellas Pharma Europe has called in Pegasus to work on a pan-European pain management franchise. The Suffolk-based agency has been charged with devising a programme to raise awareness and understanding of peripheral neuropathic pain.
ROAD, the healthcare and lifestyle specialist,has been drafted in by Niagara Healthcare to support its portfolio of therapeutic products for older consumers with mobility issues. The product portfolio includes bed brand Adjustamatic.
AstraZeneca's chief executive David Brennan is to leave the firm on 1 June following a 19 per cent profit slump in the first quarter of 2012. The company's non-executive chairman Louis Schweitzer will also step down on the same day, three months ahead of schedule.